Literature DB >> 22152481

p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage.

Adam M Schmitt1, Clayton D Crawley, Shijune Kang, David R Raleigh, Xiaohong Yu, Joshua S Wahlstrom, David J Voce, Thomas E Darga, Ralph R Weichselbaum, Bakhtiar Yamini.   

Abstract

The functional significance of the signaling pathway induced by O(6)-methylguanine (O(6)-MeG) lesions is poorly understood. Here, we identify the p50 subunit of NF-κB as a central target in the response to O(6)-MeG and demonstrate that p50 is required for S(N)1-methylator-induced cytotoxicity. In response to S(N)1-methylation, p50 facilitates the inhibition of NF-κB-regulated antiapoptotic gene expression. Inhibition of NF-κB activity is noted to be an S phase-specific phenomenon that requires the formation of O(6)-MeG:T mismatches. Chk1 associates with p50 following S(N)1-methylation, and phosphorylation of p50 by Chk1 results in the inhibition of NF-κB DNA binding. Expression of an unphosphorylatable p50 mutant blocks inhibition of NF-κB-regulated antiapoptotic gene expression and attenuates S(N)1-methylator-induced cytotoxicity. While O(6)-MeG:T-induced, p50-dependent signaling is not sufficient to induce cell death, this pathway sensitizes cells to the cytotoxic effects of DNA breaks.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22152481      PMCID: PMC3240852          DOI: 10.1016/j.molcel.2011.09.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  28 in total

1.  Substrate specificity determinants of the checkpoint protein kinase Chk1.

Authors:  J R Hutchins; M Hughes; P R Clarke
Journal:  FEBS Lett       Date:  2000-01-21       Impact factor: 4.124

Review 2.  The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

Authors:  R Fishel
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

3.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

4.  Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine.

Authors:  Mark J Hickman; Leona D Samson
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

5.  Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus.

Authors:  Andreas Birbach; Peter Gold; Bernd R Binder; Erhard Hofer; Rainer de Martin; Johannes A Schmid
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

6.  ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.

Authors:  Paul Nghiem; Peter K Park; Yong-son Kim Ys; Bimal N Desai; Stuart L Schreiber
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

7.  Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.

Authors:  Kirsteen J Campbell; Sonia Rocha; Neil D Perkins
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

8.  Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding.

Authors:  Shihe Hou; Hancheng Guan; Robert P Ricciardi
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

9.  Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.

Authors:  Amir S Karban; Toshihiko Okazaki; Carolien I M Panhuysen; Thomas Gallegos; James J Potter; Joan E Bailey-Wilson; Mark S Silverberg; Richard H Duerr; Judy H Cho; Peter K Gregersen; Yuqiong Wu; Jean-Paul Achkar; Themistocles Dassopoulos; Esteban Mezey; Theodore M Bayless; Franklin J Nouvet; Steven R Brant
Journal:  Hum Mol Genet       Date:  2003-11-12       Impact factor: 6.150

Review 10.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  29 in total

1.  The importance of the p50 NF-κB subunit.

Authors:  Neil D Perkins
Journal:  Cell Cycle       Date:  2015-08-20       Impact factor: 4.534

Review 2.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

3.  Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Authors:  David J Voce; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Wei Zhang; Nassir M Mansour; Kirk E Cahill; Szymon J Szymura; Abhineet Uppal; David R Raleigh; Ruben Spretz; Luis Nunez; Gustavo Larsen; Nikolai N Khodarev; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2019-04-02       Impact factor: 12.701

4.  BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.

Authors:  Longtao Wu; Giovanna M Bernal; Kirk E Cahill; Peter Pytel; Carrie A Fitzpatrick; Heather Mashek; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Sci Transl Med       Date:  2018-07-04       Impact factor: 17.956

5.  S-phase-dependent p50/NF-кB1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability.

Authors:  Clayton D Crawley; Shijun Kang; Giovanna M Bernal; Joshua S Wahlstrom; David J Voce; Kirk E Cahill; Andrea Garofalo; David R Raleigh; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide.

Authors:  Nassir M Mansour; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Kirk E Cahill; David J Voce; Irina V Balyasnikova; Wei Zhang; Ruben Spretz; Luis Nunez; Gustavo F Larsen; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

Review 7.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

Review 8.  Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.

Authors:  Kirk E Cahill; Ramin A Morshed; Bakhtiar Yamini
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

9.  DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site.

Authors:  Clayton D Crawley; David R Raleigh; Shijun Kang; David J Voce; Adam M Schmitt; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

10.  NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.

Authors:  Simona Caporali; Lauretta Levati; Grazia Graziani; Alessia Muzi; Maria Grazia Atzori; Enzo Bonmassar; Giuseppe Palmieri; Paolo A Ascierto; Stefania D'Atri
Journal:  J Transl Med       Date:  2012-12-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.